Anti-AMPA GluA3 antibodies in Frontotemporal dementia: a new molecular target-Reference-Cited by-同舟云学术

Anti-AMPA GluA3 antibodies in Frontotemporal dementia: a new molecular target

Published:2017-07-27 Issue:1 Volume:7 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Borroni B.,Stanic J.^ORCID,Verpelli C.,Mellone M.,Bonomi E.,Alberici A.,Bernasconi P.,Culotta L.,Zianni E.,Archetti S.,Manes M.,Gazzina S.,Ghidoni R.,Benussi L.^ORCID,Stuani C.,Di Luca M.,Sala C.,Buratti E.,Padovani A.,Gardoni F.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-017-06117-y.pdf

Reference37 articles.

1. Gorno-Tempini, M. L. et al. Classification of primary progressive aphasia and its variants. Neurology 76, 1006–1014 (2011).

2. Rascovsky, K. et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 134, 2456–2477 (2011).

3. Rohrer, J. D. et al. Patterns of cortical thinning in the language variants of frontotemporal lobar degeneration. Neurology 72, 1562–1569 (2009).

4. Bang, J., Spina, S. & Miller, B. L. Frontotemporal dementia. Lancet 386, 1672–1682 (2015).

5. Borroni, B. & Padovani, A. Dementia: a new algorithm for molecular diagnostics in FTLD. Nat. Rev. Neurol. 9(5), 241–242 (2013).

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Brain-targeting autoantibodies in patients with dementia;Frontiers in Neurology;2024-07-10

2. Low-carbohydrate diet as a disease modifier for relapse prevention of treatment-resistant depression. Spotlight on neuroplasticity and brain-derived neurotrophic factor;Medical Hypotheses;2024-06

3. Anti-GluA3 autoantibodies define a new sub-population of frontotemporal lobar degeneration patients with distinct neuropathological features;Brain, Behavior, and Immunity;2024-05

4. Pathophysiological Effects of Autoantibodies in Autoimmune Encephalitides;Cells;2023-12-20

5. Anti-NMDA and Anti-AMPA Receptor Antibodies in Central Disorders: Preclinical Approaches to Assess Their Pathological Role and Translatability to Clinic;International Journal of Molecular Sciences;2023-10-05